Barclays analyst Peter Lawson maintained a Hold rating on Blueprint Medicines (BPMC – Research Report) today and set a price target of $105.00.

Total retail sales across the UK increased by 2.6% year on year in January, according to the British Retail Consortium (BRC) ...

The bodies of Dawn Searle, 56, and Andrew Searle, 62, were discovered at their home in the small hamlet of Les Pesquiés, near ...

Speaking to the ECHO, Roger said: “I stood here on a Saturday night at half eight in the summertime last year. I looked up ...

Fintel reports that on February 6, 2025, Barclays initiated coverage of Hawaiian Electric Industries (NYSE:HE) with a ...

After a series of public market collapses, investors and bankers have strict standards for healthcare startups hoping to IPO ...

The BBC Sounds podcast host and ITV star spoke out on social media, in the wake of car insurance bills rising for drivers up ...

ECHO Everton reporter Chris Beesley gets the lowdown on the Blues' transfer deadline day signing Charly Alcaraz from Rio de ...

In a report released today, Claudia Gaspari from Barclays maintained a Buy rating on Zurich Insurance Group (ZFSVF – Research Report). The ...

People wanting to maximise their State Pension by plugging gaps in their National Insurance record have contributed to a ...

HM Revenue and Customs (HMRC) has announced that more than 11.5 million people filed their Self-Assessment tax return on time ...

The Bank of England is expected to cut interest rates this week as the UK economy continues to struggle, although the bank is ...